Glaukos Corporation Announces Third Quarter 2017 Financial Results
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced financial results for the third quarter ended September 30, 2017. Key highlights include: Achieved 37% net sales growth to $40.4 million in the third quarter of 2017, compared to $29.6 million in the third quarter of 2016. Realized